Amundi’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Amundi’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,491	Closed	-$187K	–	1918
2022 Q2	$187K	Sell	2,491 -1,191	-32%	-$52.9K	﹤0.01%	1370
2022 Q1	$98K	Buy	+3,682	New	+$124K	﹤0.01%	1475

Amundi's TPTX Position: Q3 2022 in Review

Amundi sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 2,491 shares — an estimated $187K sold.

Amundi first reported a position in TPTX in Q1 2022 and held it in 2 quarters. The position peaked at $187K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Amundi reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Amundi sold 2,491 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $187K.
Amundi first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Amundi's Turning Point Therapeutics, Inc. Common Stock position peaked at $187K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Amundi's 13F filing for Q3 2022, filed 14 Nov 2022.